BioRadar

Name: Biotech stock signal dashboard aggregating SEC-filing-derived dilution/ATM risk, FDA PDUFA and trial-catalyst calendars, insider trading activity, short interest, and social sentiment into proprietary per-ticker risk and squeeze scores
Creator: BioRadar

BIORADARManage supplier listing

Biotech stock signal dashboard aggregating SEC-filing-derived dilution/ATM risk, FDA PDUFA and trial-catalyst calendars, insider trading activity, short interest, and social sentiment into proprietary per-ticker risk and squeeze scores

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks BioRadar and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: BiotechnologyFinancial Exchanges & Data
Instruments: equities
Categories: Alternative

Dataset card

Type: not stated
Format: Tabular (structured per-ticker time-series signals and composite scores)
Volume: Likely 500-1,000+ biotech tickers tracked with daily-updated multi-signal data (cash runway, dilution risk, FDA dates, insider activity, sentiment) per ticker
Users: Request further research — no public user count disclosed; likely low thousands given a 5-person team and niche biotech-trader focus
History: 2 years
Update frequency: not stated
Growth: Active (live dashboard referencing forward-dated 2026 catalysts and continuously updated signal feeds)
Launched: est. 2024-2025 (site references upcoming 2026 catalysts as near-term, consistent with a recently launched product; modern AI-brief feature suggests post-2023 build)
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site